30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CHAPTER 14 OPIOID ANALGESICS<br />

<strong>Small</strong> dogs and cats may be dosed with half a patch,<br />

but the patch should not be cut in half. Cover half the<br />

gel membrane with tape. ‘Half-patch dosing’ is suggested<br />

for pediatric, geriatric and systemically ill cats<br />

and small dogs.<br />

The patch may be placed either on the dorsal<br />

or lateral cervical area or the lateral thorax. If the neck<br />

is used, collars/leashes cannot be placed over the patch.<br />

The thorax is easily used and contact maximized<br />

(especially in cats), but can be difficult to bandage. The<br />

site must be clean and dry at the time of application.<br />

The patch should not be placed where a heating<br />

pad may come into contact as this may increase release<br />

of drug from the patch. All patients wearing patches<br />

should have heart and respiratory rates monitored<br />

regularly.<br />

CLINICAL PHARMACOLOGY OF<br />

INDIVIDUAL OPIOID AGONISTS<br />

Choice of the most appropriate opioid analgesic, as well<br />

as its dose and route of administration in a given clinical<br />

situation, is dictated by the pharmacodynamic and<br />

pharmacokinetic factors discussed above. Table 14.2<br />

summarizes important pharmacodynamic features of<br />

the available opioids discussed below and Table 14.3<br />

lists appropriate doses and routes of administration in<br />

different species.<br />

Morphine<br />

Morphine is the opioid analgesic against which others<br />

are compared.<br />

Table 14.2 Relative activities of opioid agonists and antagonists at µ- and κ-receptors<br />

Drug Receptor activity Mu (m) Kappa (k) Analgesic efficacy<br />

Morphine Agonist ++ 0 Strong<br />

Pethidine (meperidine) Agonist + + Moderate-strong<br />

Methadone Agonist ++ 0 Strong<br />

Oxymorphone Agonist ++ 0 Very strong<br />

Fentanyl Agonist ++ + Very strong<br />

Alfentanil Agonist ++ + Very strong<br />

Codeine* Agonist + 0 Weak<br />

Tramadol** Agonist + 0 Moderate<br />

Buprenorphine Partial agonist P+ P+? Moderate<br />

Butorphanol Agonist–antagonist P+ + Moderate-weak<br />

Pentazocine Agonist–antagonist P+ ++ Moderate-weak<br />

Nalbuphine Agonist–antagonist P+? + Moderate-weak<br />

Naloxone Antagonist – - N/A<br />

Nalorphine Antagonist – P+ N/A<br />

Nalmefene Antagonist – - N/A<br />

++, Strong agonist activity; +, agonist activity; P+, partial agonist activity; 0, no activity; -, weak antagonist activity; – –, strong antagonist activity;<br />

N/A, not applicable,?, the action is very weak or absent.<br />

* Opioid actions of codeine are due exclusively to its slow metabolic conversion to morphine.<br />

** Tramadol is moderately analgesic because it is a dual µ-receptor agonist (its metabolites are more potent) and monoamine (noradrenaline<br />

and serotonin) transport inhibitor.<br />

Table 14.3 Opioid dosages and duration of action<br />

Drug Route of administration Dose rate (mg/kg) † Duration of analgesic<br />

action (h)<br />

Dog Cat ‡<br />

Agonists<br />

Morphine Intravenous 0.05–0.1 0.05 1–4 §<br />

Intraoperative bolus 0.1 0.05<br />

Intramuscular or subcutaneous 0.1–0.5 0.1–0.3 4–6<br />

Extradural 0.1–0.2 0.1–0.2 12–24<br />

Interpleural 0.5–1.0 8–12<br />

Intra-articular 0.1–1.0 8–12<br />

Oral 0.1–3.0 0.1–1.0 4–8<br />

Sustained release 1.5–3.0 N/A 8–12<br />

318

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!